Pfizer Inc.
Industry: Major Drugs

Pfizer Inc discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Our innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: health care, animal health and consumer health care. Our products are available in more than 150 countries.

Business Summary
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals, as well as consumer healthcare products. The Company operates in three business segments: Human Health (previously named Pharmaceutical), Consumer Healthcare and Animal Health. It also operates several other businesses, including the manufacture of empty soft-gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals. Pfizer completed the acquisition of Esperion Therapeutics, Inc. on February 10, 2004. Esperion is a biopharmaceutical company focused on the development of high-density lipoprotein (HDL)-targeted (good cholesterol) therapies for the treatment of cardiovascular disease.

Financial Summary
For the nine months ended 2 October 2005, Pfizer Inc.'s total revenues increased less than 1% to $37.71B. Net income from cont. ops. decreased 37% to $5.35B. Revenues reflect an increase in animal health pharmaceutical business segment. Net income was offset by the inclusion of merger-related in-process research and development charges of $1.39B, and an increase in restructuring charges and merger-related costs.